Insulin vs placebo
HbA1c (%) · adults with CFRD
1 finding from 1 review
- Drug treatments for managing cystic fibrosis‐related diabetes 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 39 participantsVery low
The review found no eligible studies for this question.
Summary of findings: repaglinide showed no clear difference in hbA1c (%) change from baseline compared with insulin (high certainty).